alnylam pharmaceuticals inc
(ALNY:Consolidated Issue Listed on NASDAQ Global Select )
Fritz Eckstein Ph.D.
Former Member of Scientific Advisory Board, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Dr. Fritz Eckstein, Ph.D., served as a Member of the Scientific Advisory Board of Alnylam Pharmaceuticals Inc. Dr. Eckstein is a Professor of Max Planck Institute.
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Hans G. C. P. Schikan||Chief Executive Officer and Member of Management Board|
Prosensa Holding N.V.
|Mark W. Schwartz Ph.D.||Chief Executive Officer and President|
Galena Biopharma, Inc.
|Mark J. Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|